Inventor
PERKINS JAMES J
US33 patents
⚠️ This page may combine multiple inventors who share the name “PERKINS JAMES J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
21 patentsUS6066648AMay 23, 2000
Integrin receptor antagonists
MERCK & CO INC67 citations96
US6410526B1Jun 25, 2002
αv integrin receptor antagonists
MERCK & CO INC40 citations92
US6358970B1Mar 19, 2002
Integrin receptor antagonists
MERCK & CO INC41 citations92
US6268378B1Jul 31, 2001
Integrin receptor antagonists
MERCK & CO INC28 citations92
US5981546ANov 9, 1999
Integrin antagonists
MERCK & CO INC45 citations92
US6211184B1Apr 3, 2001
Integrin antagonists
MERCK & CO INC21 citations91
US5648368AJul 15, 1997
Fibrinogen receptor antagonists
MERCK & CO INC49 citations91
US7186838B2Mar 6, 2007
Fluorinated 4-azasteroid derivatives as androgen receptor modulators
MERCK & CO INC16 citations84
US6472403B2Oct 29, 2002
αV integrin receptor antagonists
MERCK & CO INC20 citations84
US6211191B1Apr 3, 2001
Integrin receptor antagonists
MERCK & CO INC16 citations84
US5780480AJul 14, 1998
Fibrinogen receptor antagonists
MERCK & CO INC17 citations83
US7268153B2Sep 11, 2007
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
MERCK & CO INC14 citations82
US7365202B2Apr 29, 2008
Polymorphs of an androgen receptor modulator
MERCK & CO INC11 citations81
US7153862B2Dec 26, 2006
αv integrin receptor antagonists
MERCK & CO INC10 citations73
US7625920B2Dec 1, 2009
Fluorinated 4-azasteroid derivatives as androgen receptor modulators
MERCK & CO INC2 citations63
US6693101B2Feb 17, 2004
αv integrin receptor antagonists
MERCK & CO INC4 citations62
US7629367B2Dec 8, 2009
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
MERCK & CO INC1 citations60
US5952306ASep 14, 1999
Integrin receptor antagonists
MERCK & CO INC5 citations60
US7410977B2Aug 12, 2008
Fluorinated 4-azasteroids as androgen receptor modulators
MERCK & CO INC0 citations52
US7351698B2Apr 1, 2008
Androgen receptor modulators and methods of use thereof
MERCK & CO INC0 citations52
US7605152B2Oct 20, 2009
17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
MERCK & CO INC0 citations41
MERCK SHARP & DOHME
7 patentsUS11377438B2Jul 5, 2022
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors
MERCK SHARP & DOHME6 citations83
US9278960B2Mar 8, 2016
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME4 citations82
US9663506B2May 30, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US9636337B2May 2, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US10072003B2Sep 11, 2018
Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME1 citations51
US11802122B2Oct 31, 2023
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors
MERCK SHARP & DOHME0 citations50
US7763659B2Jul 27, 2010
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
MERCK SHARP & DOHME0 citations50
MERCK SHARP & DOHME LLC
4 patentsUS12195445B2Jan 14, 2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors
MERCK SHARP & DOHME LLC0 citations60
US12246008B2Mar 11, 2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
MERCK SHARP & DOHME LLC0 citations51
US12344595B2Jul 1, 2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors
MERCK SHARP & DOHME LLC0 citations48
US12516046B2Jan 6, 2026
2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
MERCK SHARP & DOHME LLC0 citations46